Literature DB >> 11793011

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.

Rui M Costa1, Nikolai B Federov, Jeff H Kogan, Geoffrey G Murphy, Joel Stern, Masuo Ohno, Raju Kucherlapati, Tyler Jacks, Alcino J Silva.   

Abstract

Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans. Mice carrying a heterozygous null mutation of the Nfl gene (Nfl(+/-) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity, adenylyl cyclase modulation and microtubule binding, it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1(+/-) mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1(+/-) mice have increased GABA (gamma-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793011     DOI: 10.1038/nature711

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  222 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

2.  ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.

Authors:  Yuying Wang; Joel M Brittain; Sarah M Wilson; Cynthia M Hingtgen; Rajesh Khanna
Journal:  Transl Neurosci       Date:  2010-06       Impact factor: 1.757

Review 3.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

Review 4.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

5.  HCN2 channels in local inhibitory interneurons constrain LTP in the hippocampal direct perforant path.

Authors:  Lucas Matt; Stylianos Michalakis; Franz Hofmann; Verena Hammelmann; Andreas Ludwig; Martin Biel; Thomas Kleppisch
Journal:  Cell Mol Life Sci       Date:  2010-07-10       Impact factor: 9.261

Review 6.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

7.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

8.  Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation.

Authors:  Corina Anastasaki; Nicholas Rensing; Kevin J Johnson; Michael Wong; David H Gutmann
Journal:  J Sleep Res       Date:  2019-01-04       Impact factor: 3.981

9.  Neurofibromin is the major ras inactivator in dendritic spines.

Authors:  Ana F Oliveira; Ryohei Yasuda
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

10.  State-dependent Ras signaling and AMPA receptor trafficking.

Authors:  Yi Qin; Yinghua Zhu; Joel P Baumgart; Ruth L Stornetta; Kenneth Seidenman; Volker Mack; Linda van Aelst; J Julius Zhu
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.